Humoral and cell-mediated immunity six months post BNT162b2 vaccination – News-Medical.Net

A recent study on healthcare workers in Japan has evaluated vaccine-induced humoral and cellular immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) six months post BNT162b2 (Pfizer-BioNTech, USA) vaccination.
Study: Vaccine-induced…

Click here to view the original article.